Asif Ali

CIK: 0001921163

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (48.1%)

Position reduction

Option Exercises (M)12 (44.4%)

Derivative conversions

Awards (A)2 (7.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PTGX

Protagonist Therapeutics, Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (27 total)

PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Exercise(M)
Direct
15.7K shares at avg. $19.19$300K
PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Exercise(M)
Direct
9.2K shares at avg. $38.98$360K
PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Exercise(M)
Direct
28.4K shares at avg. $23.42$666K
PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Sale(S)
Direct
46K shares at avg. $141.78$6.5M
PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Exercise(M)
Direct
5.3K shares at avg. $12.17$65K
PTGX
Protagonist Therapeutics, Inc
Sep 30, 2026
Sale(S)
Direct
12.6K shares at avg. $141.77$1.8M
PTGX
Protagonist Therapeutics, Inc
Apr 20, 2026
Sale(S)
Direct
1.8K shares at avg. $105.47$185K
PTGX
Protagonist Therapeutics, Inc
Mar 26, 2026
Sale(S)
Direct
24.8K shares at avg. $104.24$2.6M
PTGX
Protagonist Therapeutics, Inc
Mar 26, 2026
Exercise(M)
Direct
19.5K shares at avg. $19.19$374K
PTGX
Protagonist Therapeutics, Inc
Mar 26, 2026
Exercise(M)
Direct
5.3K shares at avg. $12.17$64K
PTGX
Protagonist Therapeutics, Inc
Jan 27, 2026
Exercise(M)
Direct
16K shares at avg. $19.19$307K
PTGX
Protagonist Therapeutics, Inc
Jan 27, 2026
Sale(S)
Direct
18.2K shares at avg. $83.14$1.5M
PTGX
Protagonist Therapeutics, Inc
Jan 27, 2026
Sale(S)
Direct
28K shares at avg. $83.13$2.3M
PTGX
Protagonist Therapeutics, Inc
Jan 27, 2026
Exercise(M)
Direct
12K shares at avg. $12.17$146K
PTGX
Protagonist Therapeutics, Inc
Jan 20, 2026
Sale(S)
Direct
8.6K shares at avg. $82.48$708K
PTGX
Protagonist Therapeutics, Inc
Jan 2, 2026
Award(A)
Direct
25.6K shares-
PTGX
Protagonist Therapeutics, Inc
Apr 22, 2025
Sale(S)
Direct
1.8K shares at avg. $46.00$81K
PTGX
Protagonist Therapeutics, Inc
Mar 12, 2025
Exercise(M)
Direct
15.2K shares at avg. $12.17$185K
PTGX
Protagonist Therapeutics, Inc
Mar 12, 2025
Sale(S)
Direct
24.9K shares at avg. $58.73$1.5M
PTGX
Protagonist Therapeutics, Inc
Mar 12, 2025
Exercise(M)
Direct
9.7K shares at avg. $19.19$186K
PTGX
Protagonist Therapeutics, Inc
Jan 16, 2025
Sale(S)
Direct
2.6K shares-
PTGX
Protagonist Therapeutics, Inc
Jan 16, 2025
Sale(S)
Direct
1.3K shares-
PTGX
Protagonist Therapeutics, Inc
Jan 2, 2025
Award(A)
Direct
31.8K shares-
PTGX
Protagonist Therapeutics, Inc
Sep 11, 2024
Sale(S)
Direct
2.2K shares at avg. $44.59$98K
PTGX
Protagonist Therapeutics, Inc
Sep 11, 2024
Sale(S)
Direct
12K shares at avg. $44.47$534K

		Type	Shares	Price		Ownership
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	15,650	$19.19	$300,324	Direct
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	9,229	$38.98	$359,746	Direct
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	28,438	$23.42	$666,018	Direct
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	46,034	$141.78	$6,526,701	Direct
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	5,312	$12.17	$64,647	Direct
Sep 30, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	12,595	$141.77	$1,785,593	Direct
Apr 20, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	1,750	$105.47	$184,573	Direct
Mar 26, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	24,765	$104.24	$2,581,504	Direct
Mar 26, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	19,500	$19.19	$374,205	Direct
Mar 26, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	5,265	$12.17	$64,075	Direct
Jan 27, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	16,000	$19.19	$307,040	Direct
Jan 27, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	18,203	$83.14	$1,513,397	Direct
Jan 27, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	28,000	$83.13	$2,327,640	Direct
Jan 27, 2026	PTGX Protagonist Therapeutics, Inc	Exercise(M)	12,000	$12.17	$146,040	Direct
Jan 20, 2026	PTGX Protagonist Therapeutics, Inc	Sale(S)	8,588	$82.48	$708,338	Direct
Jan 2, 2026	PTGX Protagonist Therapeutics, Inc	Award(A)	25,600	-	$0	Direct
Apr 22, 2025	PTGX Protagonist Therapeutics, Inc	Sale(S)	1,756	$46.00	$80,776	Direct
Mar 12, 2025	PTGX Protagonist Therapeutics, Inc	Exercise(M)	15,203	$12.17	$185,021	Direct
Mar 12, 2025	PTGX Protagonist Therapeutics, Inc	Sale(S)	24,903	$58.73	$1,462,553	Direct
Mar 12, 2025	PTGX Protagonist Therapeutics, Inc	Exercise(M)	9,700	$19.19	$186,143	Direct
Jan 16, 2025	PTGX Protagonist Therapeutics, Inc	Sale(S)	2,601	-	$0	Direct
Jan 16, 2025	PTGX Protagonist Therapeutics, Inc	Sale(S)	1,317	-	$0	Direct
Jan 2, 2025	PTGX Protagonist Therapeutics, Inc	Award(A)	31,779	-	$0	Direct
Sep 11, 2024	PTGX Protagonist Therapeutics, Inc	Sale(S)	2,203	$44.59	$98,232	Direct
Sep 11, 2024	PTGX Protagonist Therapeutics, Inc	Sale(S)	12,000	$44.47	$533,640	Direct

1-25 of 27 transactions

About Ali Asif

Ali Asif (SEC CIK 0001921163) files insider reports with the SEC as Chief Financial Officer of Protagonist Therapeutics, Inc (PTGX).

Signal8 holds 11 ownership filings by Ali Asif, all Form 4s, filed between Sep 13, 2024 and Oct 2, 2026. Those filings report 27 transactions, from Sep 11, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ali Asif's filings is in NEWARK, CA.

Recent filings by Ali Asif

Sep 30, 2026: Option exercises of PTGX shares (3 lines, Form 4, code M).
Sep 30, 2026: Open-market sale of PTGX shares (Form 4, code S).
Sep 30, 2026: Option exercise of PTGX shares (Form 4, code M).
Sep 30, 2026: Open-market sale of PTGX shares (Form 4, code S).
Apr 20, 2026: Open-market sale of PTGX shares (Form 4, code S).

Other insiders filing for Protagonist Therapeutics, Inc (PTGX)

PATEL DINESH V PH D, President and CEO
Waddill William D., Director
Giraudo Bryan, Director
MOLINA ARTURO MD, Chief Medical Officer
SELICK HAROLD E, Director
Williams Lewis T, Director

How to read Form 4 transaction codes